Product/Composition:- | Benzathine Penicillin Intramuscular Injection |
---|---|
Strength:- | 600,000 units / mL; 1.2 million units / mL |
Form:- | Intramuscular Injection |
Reference Brands:- | Bicillin L-A, Bicillin C-R(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Benzathine Penicillin IM inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, leading to bacterial cell lysis and death. It provides long-acting, sustained antibiotic activity, effectively treating syphilis, rheumatic fever, and streptococcal infections. Benefits include reliable, prolonged eradication of bacteria with a single injection.
Benzathine penicillin IM injection is approved in the US and EU for treating syphilis, rheumatic fever, and streptococcal infections. In the US, brands like Bicillin L-A are regulated by the FDA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards, with strict guidelines due to antibiotic resistance. In the EU, approval depends on national regulations, with dossiers required to demonstrate quality and safety. Both regions enforce stringent prescribing, storage, and usage regulations. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access, ensuring adherence to European and US standards for safe, effective antibiotic therapy while navigating complex regulatory landscapes seamlessly.